Company news
Aptargroup, Inc. (NYSE:ATR) news
Every Aptargroup, Inc. press release and news update in one place — announcements, filings coverage, and company updates for investors.
Press releases & updates
Aptar Reports Second Quarter 2026 Results
July 30, 2026
Aptar Named One of the World's Most Sustainable Companies by TIME for Third Consecutive Year
July 27, 2026
Aptar Pharma Announces GMP Certification at Nanopharm, Strengthening Its Integrated Pharma Services Offering
July 22, 2026
Aptar Beauty Launches Next-Generation Auto-Loading Dropper Technology for Easier, More Accurate Skincare Dosing
July 20, 2026
Aptar Pharma Launches Integrated System-Level Framework to Support Injectable Drug Development
July 17, 2026
Aptar Named Among Top 100 of America’s Best Companies by TIME
July 13, 2026
Aptar Releases 2025 Corporate Sustainability Report
June 18, 2026
Aptar Named a CDP Supplier Engagement Leader for the Sixth Consecutive Year
June 2, 2026
Aptar Pharma Announces New Patent Applications and Preclinical Data Supporting Investigation of Intranasal and Pulmonary GLP-1 Delivery
May 28, 2026
Aptar Advances Sustainability Features in Luxury Packaging through Patented Reloadable Airless Innovation with Clarins
May 6, 2026
AptarGroup : First Quarter 2026 Historical Financials
May 1, 2026
Aptar Reports First Quarter 2026 Results
April 30, 2026
Aptar Turns Beauty and Personal Care Products Upside Down with Inverted Lidless Dispensing Closures for Clean, Single‑Handed Dispensing
April 27, 2026
Aptar Recognized as One of America’s Climate Leaders by USA Today for the Fourth Consecutive Year
April 22, 2026
Aptar Digital Health Partners with Enable Injections for enFuse® Companion Digital Solution
April 8, 2026
Global Cosmetic Dropper Market to Reach USD 1,855.9 Million by 2036 | Asia Pacific Leads Skincare Boom; AptarGroup
April 1, 2026
Global Pump and Dispenser Market to Reach USD 84.6 Billion by 2036 Led by North America and AptarGroup Inc. Innovation
March 27, 2026
Global Aerosol Valves Market to Reach USD 3.8 Billion by 2036 as Europe Leads and AptarGroup & LINDAL Expand Capacity
March 26, 2026
Aptar’s Unidose Powder Nasal Delivery System Used in ENA Respiratory Phase II Clinical Study of Investigational INNA‑051 Nasal Spray
March 19, 2026
Aptar Announces Gael Touya as its Next Chief Executive Officer; Stephan B. Tanda to Retire by the End of the Year
March 17, 2026
Aptar’s Intranasal Delivery System Used in Phase II Clinical Study for Investigational SPONTAN® Nasal Spray
March 16, 2026
AptarGroup : Bank of America 2026 Injectable Drug Packaging Virtual Field Trip
March 2, 2026
AptarGroup : Bank of America 2026 Global Agriculture and Materials Conference
February 25, 2026
AptarGroup : Fourth Quarter 2025 Historical Financials
February 6, 2026
Aptar Reports Fourth Quarter and Annual 2025 Results
February 5, 2026
Aptar Declares Quarterly Dividend and Announces 2026 Annual Meeting Details
January 22, 2026
Aptar Again Recognized with Prestigious ‘A’ Score on the CDP Climate Change Assessment
January 21, 2026
Aptar’s Nasal Vaccine Delivery Solutions Featured in CastleVax Phase II Clinical Trial of an Intranasal COVID-19 Vaccine Candidate
January 13, 2026
Aptar’s Eye Care Solutions Designed to Improve Dosing Precision, Including Newest Technology, Beat the Blink™
January 12, 2026
Aptar Announces 2026 Quarterly Conference Call Dates
January 7, 2026
Aptar Digital Health and ŌURA Collaborate to Advance Migraine Insights by Connecting Migraine Buddy® with Oura Ring
January 6, 2026
Aptar to Present at 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026
January 5, 2026
Aptar’s Bidose Nasal System Delivers CARDAMYST™ (etripamil), the First and Only Self-Administered FDA-Approved Nasal Spray for Paroxysmal...
December 17, 2025
Aptar Named One of America’s Most Responsible Companies by Newsweek for the Seventh Consecutive Year
December 4, 2025
Aptar Acquires Sommaplast, a Specialized Provider of Oral Dosing Pharma Packaging Solutions
December 1, 2025
Aptar to Present at Jefferies Global Healthcare Conference on November 19, 2025
November 11, 2025
Aptar Reports Third Quarter 2025 Results
October 30, 2025
Aptar Digital Health Announces FDA 510(k) Clearance for HeroTracker® Sense, a Connected Add-On Device for Metered-Dose Inhalers
October 16, 2025
Aptar Named Among Top 100 of the ‘World’s Top Companies for Women 2025’ by Forbes
October 15, 2025
Aptar Increases Quarterly Dividend by Nearly 7% Signaling Continued Momentum and Long-Term Strength
September 8, 2025
Aptar Announces 2025 Investor Day
September 4, 2025
Aptar Reports Second Quarter 2025 Results
July 31, 2025
Aptar Declares Quarterly Dividend
July 10, 2025
Aptar Named One of the World’s Most Sustainable Companies by TIME for Second Consecutive Year
June 25, 2025
Aptar to Participate in Upcoming Investor Conferences
June 2, 2025
Aptar Releases 2024 Corporate Sustainability Report
May 29, 2025
Aptar Reports First Quarter 2025 Results
May 1, 2025
Aptar Announces Clinical Validation Study to Accelerate US FDA Approval of SmartTrack™ In-Vitro-in-Silico Platform for Pressurized Metere...
April 16, 2025
Aptar Receives Platinum Rating from EcoVadis for the Fifth Consecutive Year
April 15, 2025
Aptar Named One of Barron’s 100 Most Sustainable U.S. Companies for the Seventh Consecutive Year
March 27, 2025